protohypericin: structure in first source
ID Source | ID |
---|---|
PubMed CID | 164660 |
CHEMBL ID | 1078768 |
SCHEMBL ID | 19322741 |
MeSH ID | M0281453 |
Synonym |
---|
1,3,4,6,8,15-hexahydroxy-10,13-dimethyl-dibenzo[a,o]perylene-7,16-dione |
protohypericin |
CHEMBL1078768 |
548-03-8 |
dibenzo(a,o)perylene-7,16-dione, 1,3,4,6,8,15-hexahydroxy-10,11-dimethyl- |
YLILOANQCQKPOD-UHFFFAOYSA-N |
SCHEMBL19322741 |
DTXSID30203269 |
7,11,13,16,18,22-hexahydroxy-5,24-dimethylheptacyclo[13.11.1.1^{2,10}.0^{3,8}.0^{19,27}.0^{21,26}.0^{14,28}]octacosa-1,3,5,7,10,12,14(28),15,17,19(27),21,23,25-tridecaene-9,20-dione |
AKOS030631733 |
HY-N4139 |
1,3,4,6,8,15-hexahydroxy-10,13-dimethyldibenzo[a,o]perylene-7,16-dione |
BCP29229 |
CS-0032211 |
9,11,13,16,18,20-hexahydroxy-5,24-dimethylheptacyclo[13.11.1.12,10.03,8.019,27.021,26.014,28]octacosa-1,3,5,8,10,12,14(28),15(27),16,18,20,23,25-tridecaene-7,22-dione |
MS-29408 |
Excerpt | Reference | Relevance |
---|---|---|
" Their biodistribution and pharmacokinetic properties were determined in rat models of induced necrosis." | ( Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones. Feng, Y; Gao, M; Huang, D; Jiang, C; Ni, Y; Shao, H; Sun, Z; Wang, X; Yang, S; Yin, Z; Zhang, D; Zhang, J, 2016) | 0.43 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID472353 | Cytotoxicity against human THP1 cells after 48 hrs assessed morphological changes compound exposed to light for 20 mins before treatment | 2009 | Journal of natural products, Oct, Volume: 72, Issue:10 | Light-independent metabolomics of endophytic Thielavia subthermophila provides insight into microbial hypericin biosynthesis. |
AID472354 | Cytotoxicity against human THP1 cells after 48 hrs assessed as morphological changes in the dark condition | 2009 | Journal of natural products, Oct, Volume: 72, Issue:10 | Light-independent metabolomics of endophytic Thielavia subthermophila provides insight into microbial hypericin biosynthesis. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.03) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |